It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
New-onset postoperative atrial fibrillation (POAF) is common after transcatheter aortic valve replacement (TAVR). At present, the impact of POAF on cardiac remodeling after TAVR has not been thoroughly studied.
Objectives
To investigate the impact of POAF on cardiac remodeling and its association with clinical outcomes after TAVR.
Methods
601 patients undergoing TAVR for severe aortic stenosis were evaluated. Of these, 253 patients were identified to have POAF, which was categorized as normal left ventricular mass index (LVMI) in 54 (21%) and high LVMI in 199 (79%). The primary endpoint was a composite of all-cause death, heart failure rehospitalization and disabling stroke. Reverse remodeling was assessed by transthoracic echocardiography.
Results
In POAF patients, the 3-year cumulative incidence of primary composite outcome in the high LVMI subgroup was significantly higher than that in the normal LVMI subgroup (9.3 ± 3.3% vs. 13.5 ± 3.9%; p = 0.02). The incidence of LVMI regression after TAVR was lower in patients with POAF than in those without (65.6 ± 3.0% vs. 82.6 ± 2.7% at 3 years; p = 0.029). Furthermore, the 3-year cumulative incidence of the primary composite outcome and cardiovascular death was highest in the group of POAF without LVMI regression. Baseline LVMI (β = -1.73, p < 0.001) and POAF (β = -1.46, p < 0.001) were independent predictors of change in LVMI at one year.
Conclusions
Patients with POAF had less LVMI regression and impaired cardiac reverse remodeling after TAVR, which increased the incidence of all-cause death and heart failure rehospitalization. Therefore, clinicians should be more proactive in monitoring and treating POAF after TAVR.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer